Drug Trial Radar · NCT06775379
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
357
Actual
Start
Dec 20, 2024
Primary completion
Oct 28, 2026
Study completion Oct 28, 2026
Sponsor
- Lead sponsor
- Xenon Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)
Conditions
- Major Depressive Disorder
Interventions
AzetukalnerDrug
Azetukalner 20 mg taken orally once a day with food (with the evening meal when possible) for 6 weeks
PlaceboDrug
Placebo taken orally once a day with food (with the evening meal when possible) for 6 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in the Hamilton Depression Rating Scale, 17-item (HAMD-17) score at Week 6Time frame: Baseline to Week 6
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
IMA Clinical Research Phoenix
Phoenix, Arizona
Woodland International Research Group
Little Rock, Arkansas
Woodland Research Northwest
Rogers, Arkansas
Irvine Clinical Research
Irvine, California
CalNeuro Research Group, Inc.
Los Angeles, California
Excell Research Inc.
Oceanside, California
Atp Clinical Research
Orange, California
Nrc Research Institute
Orange, California
CenExel CNS-TO (Collaborative Neuroscience Research)
Torrance, California
Sunwise Clinical Research
Walnut Creek, California
Kinetic Clinical Research, LLC
West Covina, California
Ct Clinical Research Associates
Cromwell, Connecticut
CNS Clinical Research Group
Coral Springs, Florida
NeoClinical Research
Hialeah, Florida
Clinical Neuroscience Solutions, LLC
Jacksonville, Florida
Accel Research Sites Lakeland
Lakeland, Florida
Accel Research Sites - St. Petersburg-Largo
Largo, Florida
PharmaSouth Research
Miami, Florida
Quantum Clinical Trials
Miami Beach, Florida
Harmony Clinical Research Inc
North Miami Beach, Florida
Clinical Neuroscience Solutions, LLC
Orlando, Florida
Combined Research Orlando Phase I-Iv
Orlando, Florida
Panhandle Research and Medical Clinic
Pensacola, Florida
Advanced Discovery Research
Atlanta, Georgia
Synexus - Atlanta
Atlanta, Georgia
CenExel iResearch
Decatur, Georgia
Psych Atlanta, Pc
Marietta, Georgia
Cenexel Iresearch - Savannah
Savannah, Georgia
Northwest Clinical Trials Inc
Boise, Idaho
IMA Clinical Research
Chicago, Illinois
Boston Clinical Trials Llc
Boston, Massachusetts
ELIXIA
Springfield, Massachusetts
IMA Clinical Research Las Vegas
Las Vegas, Nevada
Redbird Research
Las Vegas, Nevada
Integrative Clinical Trials
Brooklyn, New York
Richmond Behavioral Associates
Staten Island, New York
New Hope Clinical Research
Charlotte, North Carolina
Neuro-Behavioral Clinical Research
North Canton, Ohio
Pahl Pharmaceutical Professionals Llc
Oklahoma City, Oklahoma
Lehigh Center For Clinical Research
Allentown, Pennsylvania
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.